Table 2. Univariate analysis of NSCLC patient clinicopathological parameters with respect to survival.

Clinicopathological parameters	Total	Survival status		P-value
		Died	Alive
Gender
Male	112	55	57	0.673
Female	28	15	13
Age
<60	43	23	20	0.583
≥60	97	47	50
Smoking status
Yes	57	23	34	0.058
No	83	47	36
Tumor size (cm)
≤3	60	24	36	0.040*
>3	80	46	34
Clinical stage (TNM)
T1+T2	125	63	62	0.785
T3+T4	15	7	8
Pathology grade
Poor	41	12	29	<0.01*
Mod	60	27	33
Well	39	31	8
Grade
I+II	93	42	51	0.107
III+IV	47	28	18
Lymph node metastasis
No	54	29	25	0.487
Yes	86	41	45
Distant metastasis status
M0	105	54	51	0.558
M1	35	16	19
DISC1 expression
Low	67	23	44	<0.01*
High	73	47	26
p-GSK3β expression
Low	66	35	31	0.498
High	74	35	39
β-catenin expression
Low	70	30	40	0.091
High	70	40	30
Cyclin D1 expression
Low	65	32	33	0.865
High	75	38	37
Ki-67 expression
Low	78	31	47	0.006*
High	62	38	23

*P<0.05 (Pearson χ² test) was considered significant.